One TCR (TCR165) from one patient but also another TCR (TCR173) from one healthy donor reactive against RFX4-86 used TRBV4-2, which has been strongly implicated in narcolepsy pathophysiology by our lab before through genetic analysis13. This evidence concerns the gene RFX4 and narcolepsy.